Literature DB >> 32908316

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.

Katharina Schubert1, Evangelos D Karousis2, Ahmad Jomaa1, Alain Scaiola1, Blanca Echeverria1, Lukas-Adrian Gurzeler2, Marc Leibundgut1, Volker Thiel3,4, Oliver Mühlemann5, Nenad Ban6.   

Abstract

The SARS-CoV-2 non-structural protein 1 (Nsp1), also referred to as the host shutoff factor, suppresses host innate immune functions. By combining cryo-electron microscopy and biochemistry, we show that SARS-CoV-2 Nsp1 binds to the human 40S subunit in ribosomal complexes, including the 43S pre-initiation complex and the non-translating 80S ribosome. The protein inserts its C-terminal domain into the mRNA channel, where it interferes with mRNA binding. We observe translation inhibition in the presence of Nsp1 in an in vitro translation system and in human cells. Based on the high-resolution structure of the 40S-Nsp1 complex, we identify residues of Nsp1 crucial for mediating translation inhibition. We further show that the full-length 5' untranslated region of the genomic viral mRNA stimulates translation in vitro, suggesting that SARS-CoV-2 combines global inhibition of translation by Nsp1 with efficient translation of the viral mRNA to allow expression of viral genes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32908316     DOI: 10.1038/s41594-020-0511-8

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  164 in total

1.  How the coronavirus infects cells - and why Delta is so dangerous.

Authors:  Megan Scudellari
Journal:  Nature       Date:  2021-07       Impact factor: 49.962

2.  Nsp1 of SARS-CoV-2 stimulates host translation termination.

Authors:  Alexey Shuvalov; Ekaterina Shuvalova; Nikita Biziaev; Elizaveta Sokolova; Konstantin Evmenov; Nikolay Pustogarov; Aleksandra Arnautova; Vera Matrosova; Tatiana Egorova; Elena Alkalaeva
Journal:  RNA Biol       Date:  2021-11-18       Impact factor: 4.652

Review 3.  RNA regulatory mechanisms that control antiviral innate immunity.

Authors:  Nandan S Gokhale; Julian R Smith; Rachel D Van Gelder; Ram Savan
Journal:  Immunol Rev       Date:  2021-08-17       Impact factor: 12.988

Review 4.  SARS-CoV-2 mutations: the biological trackway towards viral fitness.

Authors:  Parinita Majumdar; Sougata Niyogi
Journal:  Epidemiol Infect       Date:  2021-04-30       Impact factor: 2.451

Review 5.  I(nsp1)ecting SARS-CoV-2-ribosome interactions.

Authors:  Matthieu Simeoni; Théo Cavinato; Daniel Rodriguez; David Gatfield
Journal:  Commun Biol       Date:  2021-06-10

6.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

7.  SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.

Authors:  Christine Vazquez; Sydnie E Swanson; Seble G Negatu; Mark Dittmar; Jesse Miller; Holly R Ramage; Sara Cherry; Kellie A Jurado
Journal:  PLoS One       Date:  2021-06-24       Impact factor: 3.752

Review 8.  Insights into the virologic and immunologic features of SARS-COV-2.

Authors:  Ceylan Polat; Koray Ergunay
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

Review 9.  Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.

Authors:  Hakimeh Baghaei Daemi; Muhammad Fakhar-E-Alam Kulyar; Xinlin He; Chengfei Li; Morteza Karimpour; Xiaomei Sun; Zhong Zou; Meilin Jin
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

10.  Targeting the m6A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.

Authors:  Hannah M Burgess; Daniel P Depledge; Letitia Thompson; Kalanghad Puthankalam Srinivas; Rebecca C Grande; Elizabeth I Vink; Jonathan S Abebe; Wesley P Blackaby; Alan Hendrick; Mark R Albertella; Tony Kouzarides; Kenneth A Stapleford; Angus C Wilson; Ian Mohr
Journal:  Genes Dev       Date:  2021-06-24       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.